Results 211 to 220 of about 65,632 (246)
Some of the next articles are maybe not open access.

Functional Sites of the erbB-2 Receptor and Its Activator Heregulin

2000
Abstract : Over expression of the erbB-2 (HER-2/neu) receptor occurs in up to 30% of human breast cancers and correlates with aggressive disease and poor prognosis for therapy and survival. The growth factor heregulin (HRG) binds to erbB-3 or erbB-4 receptors, promotes dimmer formation with erbB-2 and induces autophosphorylation and activation of erbB ...
openaire   +1 more source

Rapid Screening Method for Antisense Oligonucleotides Against Human Growth Factor Receptor p185erbB-2

Oligonucleotides, 2004
The aim of this study was the development of an indirect cell proliferation assay as screening tool for antisense oligonucleotides. Unmodified and phosphorothioate-modified oligonucleotides with different amounts of sulfur in the DNA backbone were examined for biologic activity.
Anke, Rohmann   +5 more
openaire   +2 more sources

Expression of the c-erbB-2 gene encoding a growth factor receptor.

Princess Takamatsu symposia, 1988
The c-erbB-2 gene is a v-erbB-related proto-oncogene which encodes a protein similar to but distinct from the epidermal growth factor (EGF) receptor. In situ hybridization of metaphase spread showed that this gene is located on human chromosome 17 at q21, a specific breakpoint observed in a translocation associated with acute promyelocytic leukemia ...
T, Yamamoto   +4 more
openaire   +1 more source

Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation

Biochemistry, 1990
The erbB-1 and erbB-2 protooncogenes encode homologous membrane receptors that respectively bind epidermal growth factor (EGF) and a still incompletely characterized ligand. Binding of EGF to its receptor is known to increase tyrosine phosphorylation of the erbB-2/neu receptor in tumor cells. To investigate the mechanism of this transregulatory pathway,
R, Goldman   +3 more
openaire   +2 more sources

The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired.

Oncogene, 1993
The endocytosis of gp185erbB-2 was studied using chimeric receptors in which the intracellular domain of erbB-2, or subdomins thereof, was substituted for the corresponding regions of the epidermal growth factor (EGF) receptor. Chimeric and wild-type EGF or erbB-2 receptors were expressed in mouse NIH3T3 or NR6 fibroblasts and in a human mammary ...
A. Sorkin, P. P. Di Fiore, G. Carpenter
openaire   +2 more sources

Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.

Oncogene, 1992
p53 expression was studied in 111 primary breast cancers with a monoclonal antibody (PAb240) that reacts with an epitope in mutant p53. Epidermal growth factor receptors (EGFr) and oestrogen receptors (ER) measured by ligand binding, c-erbB-2 expression assessed by immunochemistry and lymph node status were compared with p53 staining.
E, Horak   +6 more
openaire   +1 more source

The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications.

Biochemistry and cell biology = Biochimie et biologie cellulaire, 1997
The erbB family of tyrosine kinase receptors is involved in the regulation of a variety of vital functions including cell proliferation, cell differentiation, and stress response. Alteration in the expression of erbB receptors occurs in numerous tumor types and plays an important role in cancer development, cancer progression, and susceptibility to ...
Alaoui-Jamali, M. A.   +3 more
openaire   +2 more sources

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce   +2 more
exaly  

P53, c-erbB-2 expression and steroid hormone receptors in breast carcinoma

Objective: The aim of the study was to evaluate the p53 tumor suppressor gene, c-erbB-2 and steroid hormone receptor expression in breast carcinoma by immunohistochemistry and to correlate them with different histopathologic parameters. Materials and Methods: p53, c-erbB-2, steroid hormone receptors and their correlation with age, tumor size ...
Kilinç, N, Yaldiz, M
openaire   +1 more source

Correction: Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells

Oncogene, 2023
Maria Eugenia Balañá   +6 more
openaire   +1 more source

Home - About - Disclaimer - Privacy